Intelligence Platform
Patents
Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9757425
Method and composition for synchronizing time of insemination
granted patentUS 9751931
Hepatitis C virus neutralizing antibodies and methods
granted patentUS 9750793
Multifunctional oral vaccine based on chromosome recombineering
granted patentUS 9744226
Attenuated Mannheimia haemolytica strains
granted patentUS 9738726
HER2-specific monoclonal antibodies and conjugates thereof
granted patentUS 9738703
Neutralizing antibodies to HIV-1 and their use
granted patentUS 9737478
Treatment of malaria
granted patentUS 9732359
Replication-competent adenoviral vectors
granted patentUS 9732337
RNA nanoparticles and nanotubes
granted patentUS 9730993
Engineered anthrax lethal toxin for targeted delivery
granted patentUS 9730941
Methods and compositions for the inhibition of Pin1
granted patentUS 9730911
Cannabis extracts and methods of preparing and using same
granted patentUS 9725494
Soluble CD27 (sCD27) and the use thereof
granted patentUS 9725492
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
granted patentUS 9724380
Method and compositions for synchronizing time of insemination in gilts
granted patentUS 9724376
Olive leaf powder
granted patentUS 9719080
Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic
granted patentUS 9717752
Uses of antagonists of hyaluronan signaling
granted patentUS 9713600
Method for treating metabolic syndrome
granted patentUS 9713599
Parenteral formulations of treprostinil
granted patentUS 9708392
Monoclonal antibodies against orthopoxviruses
granted patentUS 9708267
Activators of human pyruvate kinase
granted patentUS 9707289
Biochemically stabilized HIV-1 ENV trimer vaccine
granted patentUS 9707287
Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein
granted